Prihlásiť sa Zaregistrujte sa zadarmo

Podniková hodnota spoločnosti Midatech Pharma Plc

Aká je hodnota metriky Podniková hodnota spoločnosti Midatech Pharma Plc?

Hodnota metriky Podniková hodnota spoločnosti Midatech Pharma Plc je -$3.62

Aká je definícia metriky Podniková hodnota?



Podniková hodnota (Enterprise value) je miera celkovej trhovej hodnoty spoločnosti. Vypočíta sa ako trhová kapitalizácia spolu s dlhom, menšinovým podielom, a prednostných akcií mínus celková hodnota dostupných peňazí a ich ekvivalentov.

It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.

Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.

Podniková hodnota spoločností v sektore Health Care sektor na LSE v porovnaní so spoločnosťou Midatech Pharma Plc

Čomu sa venuje spoločnosť Midatech Pharma Plc?

Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Firmy s metrikou podniková hodnota podobnou spoločnosti Midatech Pharma Plc